![]() |
市场调查报告书
商品编码
1305177
全球自动内窥镜后处理市场研究报告 - 行业分析、规模、份额、增长、趋势及2023年至2030年预测Global Automated Endoscope Reprocessors Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast 2023 to 2030 |
据预测,到2030年,全球自动内窥镜后处理市场的需求将从2022年的4.3532亿美元达到近8.1294亿美元,2023-2030年的复合年增长率为8.12%。在产量方面,2022年的市场容量为XX台,预计到2030年将达到XX台,2023-2030年的复合年增长率为XX%。
自动内窥镜再处理机(AER)是用于清洗和消毒使用后的柔性内窥镜的医疗设备。柔性内窥镜是一种细长的器械,末端装有照明灯和摄像头,用于观察和执行体内手术,如胃肠道或呼吸系统手术。AER旨在实现内窥镜清洗和消毒过程的自动化,这是预防感染和确保患者安全的关键步骤。AER结合使用高级消毒剂和自动清洁循环,清除内窥镜上残留的任何生物材料或污染物。
全球内窥镜手术的日益普及是AER市场的主要驱动力。内窥镜手术作为各种疾病的诊断和治疗工具正变得越来越普遍,包括胃肠道、呼吸道和泌尿系统疾病。有关AER使用的监管审查和指导方针不断增加,导致对这些设备的需求增加。美国FDA和欧洲EMA对AER的设计、测试和使用制定了严格的指导方针,以确保其安全性和有效性。医疗机构对感染控制的日益重视也推动了对AER的需求。正确清洗和消毒内窥镜对于防止传染源传播和降低医疗相关感染风险至关重要。自动清洗消毒器的技术进步促进了更高效、更有效的清洗和消毒过程的发展。较新的AER设计有自动检漏、电子跟踪系统和先进的消毒循环等功能,提高了再处理过程的安全性和可靠性。一次性内窥镜和附件的需求不断增长,导致市场转向能够处理这些设备的自动清洗机。制造商正在开发既可重复使用又可一次性使用的设备,以满足医疗机构不断变化的需求。对于医疗机构来说,自动清洗消毒机是一种具有成本效益的解决方案,因为它们可以减少对昂贵的人工清洗和消毒过程的需求。它们还有助于延长内窥镜的使用寿命,减少频繁更换的需要。
研究报告包括波特五力模型、市场吸引力分析和价值链分析。这些工具有助于清晰了解行业结构,评估全球竞争吸引力。此外,这些工具还对全球自动内窥镜后处理市场的各个细分市场进行了全面评估。自动内窥镜再处理机行业的增长和趋势为本研究提供了整体方法。
自动内窥镜再处理机市场报告的这一部分提供了国家和地区层面细分市场的详细数据,从而帮助战略家确定各自产品或服务的目标人群以及即将到来的机会。
本节涵盖区域展望,重点介绍北美、欧洲、亚太、拉美、中东和非洲地区内窥镜自动再处理系统市场的当前和未来需求。此外,报告还重点介绍了所有主要地区各个应用领域的需求、估计和预测。
该研究报告还涵盖了市场中主要企业的综合概况以及全球竞争格局的深入分析。自动内窥镜后处理市场的主要参与者包括Custom Ultrasonics Inc.、STERIS Plc.、Hoya Corporation、Olympus Corporation、Advanced Sterilization Products Services Inc、Laboratory Anios、Getinge AB、Metull Zug AG、Steelco S.p.A.、Cantel Medical Corp.、Johnson & Johnson。本节包括竞争格局的整体视图,其中包括各种战略发展,如关键并购、未来产能、合作伙伴关系、财务概况、合作、新产品开发、新产品上市和其他发展。
*注:在公司概况中,财务细节和近期发展取决于可用性,如果是私营公司,则可能不包括在内。
The global demand for Automated Endoscope Reprocessors Market is presumed to reach the market size of nearly USD 812.94 MN by 2030 from USD 435.32 MN in 2022 with a CAGR of 8.12% under the study period 2023 - 2030. Regarding volume, the market was calculated XX Units in 2022 and forecast to touch XX Units by 2030 with a CAGR of XX% during 2023-2030.
Automated Endoscope Reprocessors (AERs) are medical devices used to clean and disinfect flexible endoscopes after use. Flexible endoscopes are long, thin instruments with a light and camera on the end that are used to visualize and perform procedures inside the body, such as in the gastrointestinal tract or respiratory system. AERs are designed to automate the process of cleaning and disinfecting endoscopes, which is a critical step in preventing infections and ensuring patient safety. AERs use a combination of high-level disinfectants and automated cleaning cycles to remove any remaining biological material or contaminants on the endoscope.
The increasing prevalence of endoscopic procedures worldwide is a major driver of the AERs market. Endoscopic procedures are becoming more common as a diagnostic and treatment tool for various medical conditions, including gastrointestinal, respiratory, and urological disorders. The increasing regulatory scrutiny and guidelines on the use of AERs have led to increased demand for these devices. US FDA and the European EMA have set strict guidelines for the design, testing, and use of AERs to ensure their safety and efficacy. The growing focus on infection control in healthcare facilities has also driven the demand for AERs. Properly cleaned and disinfected endoscopes are critical for preventing the transmission of infectious agents and reducing the risk of healthcare-associated infections. Technological advancements in AERs have led to the development of more efficient and effective cleaning and disinfection processes. Newer AERs are designed with features such as automated leak testing, electronic tracking systems, and advanced disinfection cycles that improve the safety and reliability of the reprocessing process. The growing demand for single-use endoscopes and accessories has led to a shift in the market towards AERs that can handle these devices. Manufacturers are developing AERs that can reprocess both reusable and single-use devices to meet the changing needs of healthcare facilities. AERs are a cost-effective solution for healthcare facilities as they can reduce the need for costly manual cleaning and disinfection processes. They can also help to extend the lifespan of endoscopes, reducing the need for frequent replacements.
The research report covers Porter's Five Forces Model, Market Attractiveness Analysis, and Value Chain analysis. These tools help to get a clear picture of the industry's structure and evaluate the competition attractiveness at a global level. Additionally, these tools also give an inclusive assessment of each segment in the global market of automated endoscope reprocessors. The growth and trends of automated endoscope reprocessors industry provide a holistic approach to this study.
This section of the automated endoscope reprocessors market report provides detailed data on the segments at country and regional level, thereby assisting the strategist in identifying the target demographics for the respective product or services with the upcoming opportunities.
This section covers the regional outlook, which accentuates current and future demand for the Automated Endoscope Reprocessors market across North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa. Further, the report focuses on demand, estimation, and forecast for individual application segments across all the prominent regions.
The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide. The major players in the automated endoscope reprocessors market include Custom Ultrasonics Inc., STERIS Plc., Hoya Corporation, Olympus Corporation, Advanced Sterilization Products Services Inc, Laboratory Anios, Getinge AB, Metull Zug AG, Steelco S.p.A., Cantel Medical Corp., Johnson & Johnson. This section consists of a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.
*Note - in company profiling, financial details and recent development are subject to availability or might not be covered in case of private companies